Valproic acid induces caspase 3-mediated apoptosis in microglial cells
M Dragunow1, J M Greenwood, R E Cameron
1Department of Pharmacology, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand. m.dragunow@auckland.ac.nz
Neuroscience
|April 8, 2006
Summary
Valproic acid triggers apoptosis in mouse microglial cells (BV-2) at therapeutic levels, suggesting a novel mechanism for treating neurodegenerative diseases by selectively targeting these cells.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Valproic acid is a common treatment for epilepsy and mood disorders, but its precise mechanism of action remains elusive.
- While its effects on neurons are documented, its impact on non-neuronal brain cells, like microglia, is less understood.
- Microglia play a role in neuroinflammation and neurodegenerative conditions.
Purpose of the Study:
- To investigate the effects of valproic acid on non-neuronal brain cells, specifically microglia.
- To determine if valproic acid induces cell death in microglial cells and elucidate the underlying mechanisms.
- To explore the potential therapeutic implications of valproic acid's effects on microglia in neurodegenerative diseases.
Main Methods:
- Treatment of mouse microglial BV-2 cells and macrophage RAW 264.7 cells with varying concentrations of valproic acid.
- Assessment of cell viability, apoptotic morphology, and caspase 3 cleavage.
- Bromodeoxyuridine incorporation assays to evaluate cell proliferation.
- Inhibition and potentiation studies using caspase 3 and MEK inhibitors.
Main Results:
- Valproic acid induced apoptosis in BV-2 cells at concentrations of 500-1000 microM, evidenced by reduced cell number, apoptotic morphology, and caspase 3 activation.
- Similar concentrations of valproic acid reduced cell number in RAW 264.7 cells but via reduced proliferation, not apoptosis.
- Valproic acid did not induce cell death in other tested cell lines, including neuronal and astrocyte cell lines.
- Caspase 3 inhibition blocked valproic acid-induced apoptosis, while MEK inhibition potentiated it.
Conclusions:
- Valproic acid selectively induces apoptosis in BV-2 microglial cells through a caspase 3-dependent pathway.
- This selective apoptosis of microglia suggests a potential therapeutic role for valproic acid in neurodegenerative diseases characterized by microglial activation.
- Valproic acid may alleviate conditions like Alzheimer's, Parkinson's, and HIV dementia by eliminating harmful activated microglia.
Related Concept Videos
01:30Apoptosis
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
01:24Caspases
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:17Phagocytosis of Apoptotic Cells
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Normal cells contain receptors that prevent them from being recognized by phagocytes.
01:22Cellular Injury V: Apoptosis and Autophagy
Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...